Tracked vehiclesAnduril Enterprise 0.87% fill $173.4M / $20BCBP AST 46.50% fill $929.9M / $2.0BPalantir Maven 81.60% fill $637.6M / $781.3MShield AI USCG $61.4M drawn 12 ordersCounter-drone $2.1B drawn 25 C-UAS vehicles and awardsUSAspending compile · Oct 9 2026
AwardTape

AwardTape · Defense awards · Medical · Diagnostics and lab supplies · W81K0225FA040

W81K0225FA040: $35K delivery order to Microgenics Corporation

Microgenics Corporation holds a delivery order from Department of the Army with $35K obligated since Oct 2023, against a ceiling of $35K. Latest action Apr 9, 2025.

Mdma/mda reagent kits reagent kits to test for methylenedioxymethamphetamine (mdma) and methylenedioxyamphetamine (mda) found in urine.

PIIDW81K0225FA040
Typedelivery order
Parent awardN0018924DZ018
CompanyMicrogenics Corporation
AgencyDepartment of the Army
Contracting officeW40M MRCO PACIFIC
CategoryMedical · Diagnostics and lab supplies
PSC6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Obligated since Oct 2023$35K
Total obligated (lifetime)$35K
Ceiling (base and all options)$35K
Base dateApr 9, 2025
Latest actionApr 9, 2025
End dateAug 12, 2025
Actions since Oct 20231
PricingFirm fixed price
CompetitionCompeted under simplified acquisition
Place of performanceCA
SourceUSAspending.gov record
Reporting lagDoD 90 days
About this record

Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.

Terminal: alerts on new orders and modifications to this contract, and CSV export.

7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.

Start free trial